The Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Department of Medicine, Geisel School of Medicine at Dartmouth, One Medical Center Drive, Lebanon, NH, USA.
J Gen Intern Med. 2022 Jun;37(8):1996-2002. doi: 10.1007/s11606-022-07530-4. Epub 2022 Apr 11.
Black and Hispanic people are more likely to contract COVID-19, require hospitalization, and die than White people due to differences in exposures, comorbidity risk, and healthcare access.
To examine the association of race and ethnicity with treatment decisions and intensity for patients hospitalized for COVID-19.
Retrospective cohort analysis of manually abstracted electronic medical records.
7,997 patients (62% non-Hispanic White, 16% non-Black Hispanic, and 23% Black) hospitalized for COVID-19 at 135 community hospitals between March and June 2020 MAIN MEASURES: Advance care planning (ACP), do not resuscitate (DNR) orders, intensive care unit (ICU) admission, mechanical ventilation (MV), and in-hospital mortality. Among decedents, we classified the mode of death based on treatment intensity and code status as treatment limitation (no MV/DNR), treatment withdrawal (MV/DNR), maximal life support (MV/no DNR), or other (no MV/no DNR).
Adjusted in-hospital mortality was similar between White (8%) and Black patients (9%, OR=1.1, 95% CI=0.9-1.4, p=0.254), and lower among Hispanic patients (6%, OR=0.7, 95% CI=0.6-1.0, p=0.032). Black and Hispanic patients were significantly more likely to be treated in the ICU (White 23%, Hispanic 27%, Black 28%) and to receive mechanical ventilation (White 12%, Hispanic 17%, Black 16%). The groups had similar rates of ACP (White 12%, Hispanic 12%, Black 11%), but Black and Hispanic patients were less likely to have a DNR order (White 13%, Hispanic 8%, Black 7%). Among decedents, there were significant differences in mode of death by race/ethnicity (treatment limitation: White 39%, Hispanic 17% (p=0.001), Black 18% (p<0.0001); treatment withdrawal: White 26%, Hispanic 43% (p=0.002), Black 28% (p=0.542); and maximal life support: White 21%, Hispanic 26% (p=0.308), Black 36% (p<0.0001)).
Hospitalized Black and Hispanic COVID-19 patients received greater treatment intensity than White patients. This may have simultaneously mitigated disparities in in-hospital mortality while increasing burdensome treatment near death.
由于暴露、合并症风险和医疗保健获取方面的差异,黑人和西班牙裔人比白人更容易感染 COVID-19、需要住院治疗和死亡。
研究种族和民族与因 COVID-19 住院患者的治疗决策和强度的关系。
手动提取电子病历的回顾性队列分析。
2020 年 3 月至 6 月期间,在 135 家社区医院住院治疗 COVID-19 的 7997 名患者(62%为非西班牙裔白人,16%为非黑西班牙裔,23%为黑人)
预先医疗指示(ACP)、不复苏(DNR)命令、重症监护病房(ICU)入院、机械通气(MV)和住院死亡率。在死者中,我们根据治疗强度和代码状态将死亡模式分类为治疗限制(无 MV/DNR)、治疗撤销(MV/DNR)、最大生命支持(MV/no DNR)或其他(无 MV/no DNR)。
调整后的住院死亡率在白人(8%)和黑人患者(9%,OR=1.1,95%CI=0.9-1.4,p=0.254)之间相似,而在西班牙裔患者中较低(6%,OR=0.7,95%CI=0.6-1.0,p=0.032)。黑人和西班牙裔患者更有可能入住 ICU(白人 23%,西班牙裔 27%,黑人 28%)并接受机械通气(白人 12%,西班牙裔 17%,黑人 16%)。这些组的 ACP 率相似(白人 12%,西班牙裔 12%,黑人 11%),但黑人和西班牙裔患者不太可能有 DNR 医嘱(白人 13%,西班牙裔 8%,黑人 7%)。在死者中,种族/民族存在明显的死亡方式差异(治疗限制:白人 39%,西班牙裔 17%(p=0.001),黑人 18%(p<0.0001);治疗撤销:白人 26%,西班牙裔 43%(p=0.002),黑人 28%(p=0.542);最大生命支持:白人 21%,西班牙裔 26%(p=0.308),黑人 36%(p<0.0001))。
住院的 COVID-19 黑人和西班牙裔患者比白人患者接受了更高的治疗强度。这可能同时减轻了住院死亡率方面的差异,同时增加了临终时负担过重的治疗。